QA: ALIMERA SCIENCES INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001267602_2019_ALIMERA_SCIENCES_INC.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest'}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('stock_price')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001267602, ALIMERA SCIENCES INC

  xvar xval
0 AssetsCurrent 34,848,000
1 IntangibleAssetsNetIncludingGoodwill 16,723,000
2 PropertyPlantAndEquipmentNet 1,355,000
3 remainder_Assets 1,182,000
4 LiabilitiesCurrent 10,234,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,525,000
9 ResearchAndDevelopmentExpense 11,274,000
10 remainder_Expenses 35,722,000
11 remainder_Revenues 46,970,000
12 remainder_NetIncome -1,831,000
13 remainder_ComprehensiveNetIncome -190,000
  yvar yval
0 Assets 54,108,000
1 Liabilities 10,234,000
2 Expenses 61,521,000
3 Revenues 46,970,000
4 StockholdersEquity 43,874,000
5 NetIncome -16,382,000
6 ComprehensiveNetIncome -16,477,000
7 BaseVar 87,427,000
8 EconomicCapitalRatio 1.83

Edgar->Model Mapping

Feature Distribution

Change over Time